Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
The impact of the total macular hyperpigmentation on the onset of persistent choroidal hypertransmission defects in intermediate AMD
Author Affiliations & Notes
  • Alessandro Berni
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Mengxi Shen
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Yuxuan Cheng
    Department of Bioengineering, University of Washington, Seattle, Washington, United States
  • Gissel Herrera
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Farhan Hiya
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jeremy Liu
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Liang Wang
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jianqing Li
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Omer Trivizki
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Department of Ophthalmology, Tel Aviv Medical Center, University of Tel Aviv, Tel Aviv, Israel
  • Robert O'Brien
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Giovanni Gregori
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Ruikang K Wang
    Department of Bioengineering, University of Washington, Seattle, Washington, United States
    Department of Ophthalmology, University of Washington, Seattle, Washington, United States
  • Philip J Rosenfeld
    Department of Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Alessandro Berni None; Mengxi Shen None; Yuxuan Cheng None; Gissel Herrera None; Farhan Hiya None; Jeremy Liu None; Liang Wang None; Jianqing Li None; Omer Trivizki TrueMed, Code C (Consultant/Contractor), PercieveBIO, Code R (Recipient); Robert O'Brien None; Giovanni Gregori Carl Zeiss Meditec, Code F (Financial Support); Ruikang Wang Carl Zeiss Meditec, Code C (Consultant/Contractor), Carl Zeiss Meditec, Colgate Palmolive Company, Estee Lauder Inc , Code F (Financial Support); Philip Rosenfeld Annexon, Apellis, Bayer, Boehringer-Ingelheim, Carl Zeiss Meditec, Genentech/Roche, InflammX, Ocudyne, Regeneron, Unity Biotechnology, Code C (Consultant/Contractor), Carl Zeiss Meditec, Gyroscope Therapeutics, Code F (Financial Support), Apellis, InflammX, Ocudyne, Valitor, Code I (Personal Financial Interest)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1023. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alessandro Berni, Mengxi Shen, Yuxuan Cheng, Gissel Herrera, Farhan Hiya, Jeremy Liu, Liang Wang, Jianqing Li, Omer Trivizki, Robert O'Brien, Giovanni Gregori, Ruikang K Wang, Philip J Rosenfeld; The impact of the total macular hyperpigmentation on the onset of persistent choroidal hypertransmission defects in intermediate AMD. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1023.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The natural history of total macular hyperpigmentation (hyperPig) in eyes with intermediate AMD (iAMD) was studied using swept-source optical coherence tomography (SS-OCT) to determine its association with the onset of persistent choroidal hypertransmission defects (hyperTDs).

Methods : Retrospective review of eyes with iAMD from subjects enrolled in a prospective SS-OCT study who were imaged using 6x6mm SS-OCT angiography (SS-OCTA) scans at baseline and at follow-up visits. En face sub-retinal pigment epithelium (RPE) slabs (64-400 µm beneath Bruch's membrane) were used to identify persistent choroidal hyperTDs. The same subRPE slab was used to identify choroidal hypotransmission defects attributable to hyperPig based on corresponding B-scans and defined as either RPE thickening or intraretinal hyperreflective foci. A semiautomated algorithm was used by two independent graders to validate and refine the outlines of hyperPig foci. The hyperPig area and the drusen volume within a 5mm fovea-centered circle were measured at each visit.

Results : Median follow-up for the 171 eyes from 121 patients in this study was 59.1 months (95% CI: 52.0 to 67.8 months), and 82 eyes developed at least one persistent hyperTD during follow-up. The average baseline hyperPig area measurements differed significantly between eyes that developed hyperTDs (0.085±0.128 mm2) compared with those that did not (0.022±0.053 mm2), P<.001. The hyperPig area increased over time, reaching 0.153±0.183 mm2 one year before the appearance of the first hyperTD compared with 0.075 ± 0.127 mm2 one year before the last available follow-up visit for the non-hyperTD group (P=.002). A hyperPig area of 0.07 mm2 was found to be a significant predictor of hyperTD onset within one year (P<.001). While drusen volume was also a predictor of hyperTD onset, multivariable Cox regression analysis showed that the hyperPig area remained the only significant predictor for hyperTD onset (P<.001).

Conclusions : Total macular hyperPig, which includes both hyperPig along the RPE and within the retina, is an important predictor of disease progression from iAMD to the onset of persistent hyperTDs and a key OCT biomarker for patient selection in future clinical trials.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×